story of the week
When All Is Said and Done, Screening Decreases Prostate Cancer Mortality: ERSPC and PLCO Trials
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
Ann. Intern. Med 2017 Oct 03;167(7)449-455, A Tsodikov, R Gulati, EAM Heijnsdijk, PF Pinsky, SM Moss, S Qiu, TM de Carvalho, J Hugosson, CD Berg, A Auvinen, GL Andriole, MJ Roobol, ED Crawford, V Nelen, M Kwiatkowski, M Zappa, M Luján, A Villers, EJ Feuer, HJ de Koning, AB Mariotto, R EtzioniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.